Comparing Buprenorphine vs Sublocade
| Buprenorphine | Sublocade |
|
|---|
| Buprenorphine | Sublocade (buprenorphine) |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Buprenorphine is a potent analgesic that should be only used to treat moderate to severe pain or for the treatment of opioid addiction under strict conditions. Different formulations of the drug... View more |
Prescription only
Sublocade is a once-monthly injection that may be used to treat adults with opioid use disorder and is administered subcutaneously (under the skin) into the abdomen. It forms a depot under the skin... View more |
Related suggestions Opioid Use Disorder
Opiate Dependence - Maintenance
|
|||||||||||||||
| More about Buprenorphine | More about Sublocade (buprenorphine) | ||||||||||||||||
| Ratings & Reviews | |||||||||||||||||
|
Buprenorphine has an average rating of 6.7 out of 10 from a total of 1127 ratings on Drugs.com. 58% of reviewers reported a positive effect, while 26% reported a negative effect. |
Sublocade has an average rating of 7.9 out of 10 from a total of 298 ratings on Drugs.com. 73% of reviewers reported a positive effect, while 14% reported a negative effect. |
||||||||||||||||
| Drug Class | |||||||||||||||||
|
None |
|||||||||||||||||
| Side Effects | |||||||||||||||||
|
See also: buprenorphine side effects in more detail. |
See also: Sublocade side effects in more detail. |
||||||||||||||||
| Generic Availability | |||||||||||||||||
|
Lower cost generic |
|||||||||||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||||||||||
View all buprenorphine prices |
View all Sublocade prices |
||||||||||||||||
| Dosage Forms Available | |||||||||||||||||
|
|
||||||||||||||||
| Brand Names | |||||||||||||||||
| Belbuca, Brixadi, Buprenex, Butrans, Sublocade | Other buprenorphine brands include: Belbuca, Brixadi, Buprenex, Butrans | ||||||||||||||||
| Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | |||||||||||||||||
|
48 hours |
48 hours |
||||||||||||||||
| CSA Schedule ** View glossary of terms | |||||||||||||||||
|
Moderate abuse potential
Has a potential for abuse less than those in schedules 1 and 2. Has a currently accepted medical use in treatment in the United States. Abuse may lead to moderate or low physical dependence or high psychological dependence. |
Moderate abuse potential
Has a potential for abuse less than those in schedules 1 and 2. Has a currently accepted medical use in treatment in the United States. Abuse may lead to moderate or low physical dependence or high psychological dependence. |
||||||||||||||||
| Pregnancy Category | |||||||||||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | |||||||||||||||||
|
A total of 693 drugs are known to interact with buprenorphine:
|
A total of 693 drugs are known to interact with Sublocade:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
|
|
||||||||||||||||
| Disease Interactions | |||||||||||||||||
| First Approval Date | |||||||||||||||||
|
December 29, 1981 |
November 30, 2017 |
||||||||||||||||
| WADA Class View World Anti-Doping Agency classifications. | |||||||||||||||||
| More Information | |||||||||||||||||
| Patient resources | |||||||||||||||||
| Professional Resources | |||||||||||||||||
| Related Treatment Guide | |||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.